These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34071003)

  • 1. Reduction of Superoxide Dismutase 1 Delays Regeneration of Cardiotoxin-Injured Skeletal Muscle in KK/Ta-
    Takahashi Y; Shimizu T; Kato S; Nara M; Suganuma Y; Sato T; Morii T; Yamada Y; Fujita H
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOD1, but not SOD3, deficiency accelerates diabetic renal injury in C57BL/6-Ins2(Akita) diabetic mice.
    Fujita H; Fujishima H; Takahashi K; Sato T; Shimizu T; Morii T; Shimizu T; Shirasawa T; Qi Z; Breyer MD; Harris RC; Yamada Y; Takahashi T
    Metabolism; 2012 Dec; 61(12):1714-24. PubMed ID: 22632894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of renal superoxide dismutase in progressive diabetic nephropathy.
    Fujita H; Fujishima H; Chida S; Takahashi K; Qi Z; Kanetsuna Y; Breyer MD; Harris RC; Yamada Y; Takahashi T
    J Am Soc Nephrol; 2009 Jun; 20(6):1303-13. PubMed ID: 19470681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired macrophage and satellite cell infiltration occurs in a muscle-specific fashion following injury in diabetic skeletal muscle.
    Krause MP; Al-Sajee D; D'Souza DM; Rebalka IA; Moradi J; Riddell MC; Hawke TJ
    PLoS One; 2013; 8(8):e70971. PubMed ID: 23951058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2(Akita) diabetic mice.
    Fujita H; Fujishima H; Morii T; Sakamoto T; Komatsu K; Hosoba M; Narita T; Takahashi K; Takahashi T; Yamada Y
    Hypertens Res; 2012 Feb; 35(2):213-20. PubMed ID: 22072110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salutary effect of fenofibrate on type 1 diabetic retinopathy via inhibiting oxidative stress-mediated Wnt/β-catenin pathway activation.
    Liu Q; Zhang X; Cheng R; Ma JX; Yi J; Li J
    Cell Tissue Res; 2019 May; 376(2):165-177. PubMed ID: 30610453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice.
    Gurley SB; Mach CL; Stegbauer J; Yang J; Snow KP; Hu A; Meyer TW; Coffman TM
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F788-95. PubMed ID: 20042456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-cholesterol diet augments endothelial dysfunction via elevated oxidative stress and reduced tetrahydrobiopterin in Ins2(Akita) mice, an autosomal dominant mutant type 1 diabetic model.
    Yang XQ; Chen AF
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):764-9. PubMed ID: 19207718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy.
    Tchekneva EE; Rinchik EM; Polosukhina D; Davis LS; Kadkina V; Mohamed Y; Dunn SR; Sharma K; Qi Z; Fogo AB; Breyer MD
    J Am Soc Nephrol; 2007 Jan; 18(1):103-12. PubMed ID: 17151334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual inhibition of SGLT2 and DPP-4 promotes natriuresis and improves glomerular hemodynamic abnormalities in KK/Ta-Ins2
    Fujita H; Otomo H; Takahashi Y; Yamada Y
    Biochem Biophys Res Commun; 2022 Dec; 635():84-91. PubMed ID: 36265286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse.
    Liu GC; Fang F; Zhou J; Koulajian K; Yang S; Lam L; Reich HN; John R; Herzenberg AM; Giacca A; Oudit GY; Scholey JW
    Diabetologia; 2012 Sep; 55(9):2522-32. PubMed ID: 22653270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginase-2 mediates diabetic renal injury.
    Morris SM; Gao T; Cooper TK; Kepka-Lenhart D; Awad AS
    Diabetes; 2011 Nov; 60(11):3015-22. PubMed ID: 21926276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the gene for adiponectin accelerates diabetic nephropathy in the Ins2 (+/C96Y) mouse.
    Fang F; Bae EH; Hu A; Liu GC; Zhou X; Williams V; Maksimowski N; Lu C; Konvalinka A; John R; Scholey JW
    Diabetologia; 2015 Jul; 58(7):1668-78. PubMed ID: 25957229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic myopathy differs between Ins2Akita+/- and streptozotocin-induced Type 1 diabetic models.
    Krause MP; Riddell MC; Gordon CS; Imam SA; Cafarelli E; Hawke TJ
    J Appl Physiol (1985); 2009 May; 106(5):1650-9. PubMed ID: 19246652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of lipoic acid synthase accelerates diabetic nephropathy.
    Yi X; Xu L; Hiller S; Kim HS; Nickeleit V; James LR; Maeda N
    J Am Soc Nephrol; 2012 Jan; 23(1):103-11. PubMed ID: 22021711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased superoxide contributes to enhancement of vascular contraction in Ins2(Akita) diabetic mice, an autosomal dominant mutant model.
    Yang XQ; Wang YY; Chen AF
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1097-103. PubMed ID: 18788099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspartic acid supplementation ameliorates symptoms of diabetic kidney disease in mice.
    Ichikawa S; Gohda T; Murakoshi M; Li Z; Adachi E; Koshida T; Suzuki Y
    FEBS Open Bio; 2020 Jun; 10(6):1122-1134. PubMed ID: 32301275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of diabetic nephropathy in Ins2(+/)⁻(AkitaJ) mice by the mitochondria-targeted therapy MitoQ.
    Chacko BK; Reily C; Srivastava A; Johnson MS; Ye Y; Ulasova E; Agarwal A; Zinn KR; Murphy MP; Kalyanaraman B; Darley-Usmar V
    Biochem J; 2010 Nov; 432(1):9-19. PubMed ID: 20825366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium-glucose cotransporter 2 inhibition attenuates protein overload in renal proximal tubule via suppression of megalin O-GlcNacylation in progressive diabetic nephropathy.
    Otomo H; Nara M; Kato S; Shimizu T; Suganuma Y; Sato T; Morii T; Yamada Y; Fujita H
    Metabolism; 2020 Dec; 113():154405. PubMed ID: 33069809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential.
    Fujita H; Morii T; Fujishima H; Sato T; Shimizu T; Hosoba M; Tsukiyama K; Narita T; Takahashi T; Drucker DJ; Seino Y; Yamada Y
    Kidney Int; 2014 Mar; 85(3):579-89. PubMed ID: 24152968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.